Clinical Relevance in Early Postoperative Treatment of Patients Who Have Undergone Gastric Surgery
Kyung-Myung Sohn1,
Sung-Yong Lee and
Oh-Han Kwon
1 All authors: Department of Radiology, Our Lady of Mercy Hospital, The Catholic
University of Korea, College of Medicine, 665 PupyungDong, PupyungGu, Inchon
403-720, South Korea.
Fig. 1A.45-year-old woman on day 7 after subtotal gastrectomy. Axial
CT scans were obtained at level of kidneys before (A) and 1 hr 30 min
after (B) oral administration of Gastrografin (methylglucamine
diatrizoate; Schering, Berlin, Germany). Opacification of both renal
collecting systems is seen in B.
Fig. 1B.45-year-old woman on day 7 after subtotal gastrectomy. Axial
CT scans were obtained at level of kidneys before (A) and 1 hr 30 min
after (B) oral administration of Gastrografin (methylglucamine
diatrizoate; Schering, Berlin, Germany). Opacification of both renal
collecting systems is seen in B.
Fig. 2A.64-year-old woman on day 7 after total gastrectomy. Axial CT
scans obtained at level of urinary bladder before (A) and 1 hr 30 min
after (B) oral administration of Gastrografin (methylglucamine
diatrizoate; Schering, Berlin, Germany) reveal differences in attenuation in
dependent portion of urinary bladder. Maximal attenuation difference is 46 H
in 0.6 cm2 region of interest (labeled 1, A and
B).
Fig. 2B.64-year-old woman on day 7 after total gastrectomy. Axial CT
scans obtained at level of urinary bladder before (A) and 1 hr 30 min
after (B) oral administration of Gastrografin (methylglucamine
diatrizoate; Schering, Berlin, Germany) reveal differences in attenuation in
dependent portion of urinary bladder. Maximal attenuation difference is 46 H
in 0.6 cm2 region of interest (labeled 1, A and
B).